Indication
Pediatric Relapsed
1 clinical trial
3 products
Clinical trial
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute LeukemiasStatus: Not yet recruiting, Estimated PCD: 2028-12-31
Product
ZiftomenibProduct
VenetoclaxProduct
Azacitidine